Elena Chartoff - Publications

Affiliations: 
Harvard University, Cambridge, MA, United States 

49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Conway SM, Puttick D, Russell S, Potter D, Roitman MF, Chartoff EH. Females are less sensitive than males to the motivational- and dopamine-suppressing effects of kappa opioid receptor activation. Neuropharmacology. 146: 231-241. PMID 30528327 DOI: 10.1016/j.neuropharm.2018.12.002  0.52
2017 Der-Avakian A, D'Souza MS, Potter DN, Chartoff EH, Carlezon WA, Pizzagalli DA, Markou A. Social defeat disrupts reward learning and potentiates striatal nociceptin/orphanin FQ mRNA in rats. Psychopharmacology. PMID 28280884 DOI: 10.1007/s00213-017-4584-y  1
2017 Mavrikaki M, Pravetoni M, Page S, Potter D, Chartoff E. Oxycodone self-administration in male and female rats. Psychopharmacology. PMID 28127624 DOI: 10.1007/s00213-017-4536-6  0.52
2016 Russell SE, Puttick DJ, Sawyer AM, Potter DN, Mague S, Carlezon WA, Chartoff EH. Nucleus Accumbens AMPA Receptors Are Necessary for Morphine-Withdrawal-Induced Negative-Affective States in Rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 5748-62. PMID 27225765 DOI: 10.1523/JNEUROSCI.2875-12.2016  1
2016 Chartoff EH, McHugh RK. Translational Studies of Sex Differences in Sensitivity to Opioid Addiction. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 41: 383-4. PMID 26657961 DOI: 10.1038/npp.2015.272  1
2015 Chartoff EH, Mavrikaki M. Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction. Frontiers in Neuroscience. 9: 466. PMID 26733781 DOI: 10.3389/fnins.2015.00466  1
2015 Chartoff EH, Ebner SR, Sparrow A, Potter D, Baker PM, Ragozzino ME, Roitman MF. Relative Timing Between Kappa Opioid Receptor Activation and Cocaine Determines the Impact on Reward and Dopamine Release. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26239494 DOI: 10.1038/npp.2015.226  0.52
2015 Fortin SM, Chartoff EH, Roitman MF. The Aversive Agent Lithium Chloride Suppresses Phasic Dopamine Release Through Central GLP-1 Receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26211731 DOI: 10.1038/npp.2015.220  0.32
2015 Dow AL, Lin TV, Chartoff EH, Potter D, McPhie DL, Van't Veer AV, Knoll AT, Lee KN, Neve RL, Patel TB, Ongur D, Cohen BM, Carlezon WA. Sprouty2 in the dorsal hippocampus regulates neurogenesis and stress responsiveness in rats. Plos One. 10: e0120693. PMID 25822989 DOI: 10.1371/journal.pone.0120693  1
2015 Yap JJ, Chartoff EH, Holly EN, Potter DN, Carlezon WA, Miczek KA. Social defeat stress-induced sensitization and escalated cocaine self-administration: the role of ERK signaling in the rat ventral tegmental area. Psychopharmacology. 232: 1555-69. PMID 25373870 DOI: 10.1007/s00213-014-3796-7  1
2015 Chartoff EH, Ebner SR, Sparrow A, Potter D, Baker PM, Ragozzino ME, Roitman MF. Relative Timing Between Kappa Opioid Receptor Activation and Cocaine Determines the Impact on Reward and Dopamine Release Neuropsychopharmacology. DOI: 10.1038/npp.2015.226  1
2015 Fortin SM, Chartoff EH, Roitman MF. The Aversive Agent Lithium Chloride Suppresses Phasic Dopamine Release Through Central GLP-1 Receptors Neuropsychopharmacology. DOI: 10.1038/npp.2015.220  1
2014 Chartoff EH, Carlezon WA. Drug withdrawal conceptualized as a stressor. Behavioural Pharmacology. 25: 473-92. PMID 25083570 DOI: 10.1097/FBP.0000000000000080  1
2014 Pravetoni M, Pentel PR, Potter DN, Chartoff EH, Tally L, LeSage MG. Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats. Plos One. 9: e101807. PMID 25025380 DOI: 10.1371/journal.pone.0101807  1
2014 Chartoff EH, Connery HS. It's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system. Frontiers in Pharmacology. 5: 116. PMID 24904419 DOI: 10.3389/fphar.2014.00116  1
2014 Holland FH, Ganguly P, Potter DN, Chartoff EH, Brenhouse HC. Early life stress disrupts social behavior and prefrontal cortex parvalbumin interneurons at an earlier time-point in females than in males. Neuroscience Letters. 566: 131-6. PMID 24565933 DOI: 10.1016/j.neulet.2014.02.023  1
2014 Sromek AW, Provencher BA, Russell S, Chartoff E, Knapp BI, Bidlack JM, Neumeyer JL. Preliminary pharmacological evaluation of enantiomeric morphinans. Acs Chemical Neuroscience. 5: 93-9. PMID 24393077 DOI: 10.1021/cn400205z  1
2014 Russell SE, Rachlin AB, Smith KL, Muschamp J, Berry L, Zhao Z, Chartoff EH. Sex differences in sensitivity to the depressive-like effects of the kappa opioid receptor agonist U-50488 in rats. Biological Psychiatry. 76: 213-22. PMID 24090794 DOI: 10.1016/j.biopsych.2013.07.042  1
2013 Provencher BA, Sromek AW, Li W, Russell S, Chartoff E, Knapp BI, Bidlack JM, Neumeyer JL. Synthesis and pharmacological evaluation of aminothiazolomorphinans at the mu and kappa opioid receptors. Journal of Medicinal Chemistry. 56: 8872-8. PMID 24107104 DOI: 10.1021/jm401290y  1
2013 Cone JJ, Chartoff EH, Potter DN, Ebner SR, Roitman MF. Prolonged high fat diet reduces dopamine reuptake without altering DAT gene expression. Plos One. 8: e58251. PMID 23516454 DOI: 10.1371/journal.pone.0058251  1
2013 Van't Veer A, Bechtholt AJ, Onvani S, Potter D, Wang Y, Liu-Chen LY, Schütz G, Chartoff EH, Rudolph U, Cohen BM, Carlezon WA. Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1585-97. PMID 23446450 DOI: 10.1038/npp.2013.58  1
2012 Chartoff E, Sawyer A, Rachlin A, Potter D, Pliakas A, Carlezon WA. Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats. Neuropharmacology. 62: 167-76. PMID 21736885 DOI: 10.1016/j.neuropharm.2011.06.014  1
2011 Chartoff EH, Damez-Werno D, Sonntag KC, Hassinger L, Kaufmann DE, Peterson J, McPhie D, Cataldo AM, Cohen BM. Detection of intranasally delivered bone marrow-derived mesenchymal stromal cells in the lesioned mouse brain: a cautionary report. Stem Cells International. 2011: 586586. PMID 22190964 DOI: 10.4061/2011/586586  1
2011 Potter DN, Damez-Werno D, Carlezon WA, Cohen BM, Chartoff EH. Repeated exposure to the κ-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity. Biological Psychiatry. 70: 744-53. PMID 21757186 DOI: 10.1016/j.biopsych.2011.05.021  1
2010 Ebner SR, Roitman MF, Potter DN, Rachlin AB, Chartoff EH. Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens. Psychopharmacology. 210: 241-52. PMID 20372879 DOI: 10.1007/s00213-010-1836-5  1
2009 Carlezon WA, Chartoff E. Perspective: Progress on the study and treatment of depressive illness. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1361-2. PMID 19242407 DOI: 10.1038/npp.2009.16  1
2009 Chartoff EH, Barhight MF, Mague SD, Sawyer AM, Carlezon WA. Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats. Psychopharmacology. 204: 227-39. PMID 19148621 DOI: 10.1007/s00213-008-1454-7  1
2009 Do Carmo GP, Folk JE, Rice KC, Chartoff E, Carlezon WA, Negus SS. The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats. European Journal of Pharmacology. 604: 58-65. PMID 19133255 DOI: 10.1016/j.ejphar.2008.12.021  1
2009 Chartoff EH, Papadopoulou M, MacDonald ML, Parsegian A, Potter D, Konradi C, Carlezon WA. Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue. Molecular Pharmacology. 75: 704-12. PMID 19106229 DOI: 10.1124/mol.108.051417  1
2009 Kenny PJ, Chartoff E, Roberto M, Carlezon WA, Markou A. NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 266-81. PMID 18418357 DOI: 10.1038/npp.2008.58  1
2008 Tomasiewicz HC, Todtenkopf MS, Chartoff EH, Cohen BM, Carlezon WA. The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward. Biological Psychiatry. 64: 982-8. PMID 18639235 DOI: 10.1016/j.biopsych.2008.05.029  1
2008 Chartoff EH, Potter D, Damez-Werno D, Cohen BM, Carlezon WA. Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2676-87. PMID 18185499 DOI: 10.1038/sj.npp.1301659  1
2008 Chartoff EH, Potter D, Damez-Werno D, Cohen BM, Carlezon WA. Exposure to the selective κ-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats (Neuropsychopharmacology (2008) (7) DOI: 10.1038/sj.npp.1301659) Neuropsychopharmacology. 33: 2550. DOI: 10.1038/npp.2008.63  1
2007 Carlezon WA, Chartoff EH. Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nature Protocols. 2: 2987-95. PMID 18007634 DOI: 10.1038/nprot.2007.441  1
2007 Carlezon WA, Chartoff EH. Extreme chipping: addiction to a high-fat diet? Biological Psychiatry. 61: 1019-20. PMID 17434011 DOI: 10.1016/j.biopsych.2007.03.004  1
2006 Kasim S, Blake BL, Fan X, Chartoff E, Egami K, Breese GR, Hess EJ, Jinnah HA. The role of dopamine receptors in the neurobehavioral syndrome provoked by activation of L-type calcium channels in rodents. Developmental Neuroscience. 28: 505-17. PMID 17028428 DOI: 10.1159/000095113  1
2006 Chartoff EH, Mague SD, Barhight MF, Smith AM, Carlezon WA. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 6450-7. PMID 16775132 DOI: 10.1523/JNEUROSCI.0491-06.2006  1
2006 Chartoff EH, Pliakas AM, Carlezon WA. Microinjection of the L-type calcium channel antagonist diltiazem into the ventral nucleus accumbens shell facilitates cocaine-induced conditioned place preferences. Biological Psychiatry. 59: 1236-9. PMID 16458265 DOI: 10.1016/j.biopsych.2005.09.024  1
2006 Goussakov I, Chartoff EH, Tsvetkov E, Gerety LP, Meloni EG, Carlezon WA, Bolshakov VY. LTP in the lateral amygdala during cocaine withdrawal. The European Journal of Neuroscience. 23: 239-50. PMID 16420433 DOI: 10.1111/j.1460-9568.2005.04538.x  1
2005 Pandey SC, Chartoff EH, Carlezon WA, Zou J, Zhang H, Kreibich AS, Blendy JA, Crews FT. CREB gene transcription factors: role in molecular mechanisms of alcohol and drug addiction. Alcoholism, Clinical and Experimental Research. 29: 176-84. PMID 15714041 DOI: 10.1097/01.ALC.0000153550.31168.1D  1
2005 Chartoff EH, Heusner CL, Palmiter RD. Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1324-33. PMID 15688082 DOI: 10.1038/sj.npp.1300678  1
2004 Chartoff EH, Szczypka MS, Palmiter RD, Dorsa DM. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy. Brain Research. 1022: 71-80. PMID 15353215 DOI: 10.1016/j.brainres.2004.06.061  1
2003 Chartoff EH, Papadopoulou M, Konradi C, Carlezon WA. Effects of naloxone-precipitated morphine withdrawal on glutamate-mediated signaling in striatal neurons in vitro. Annals of the New York Academy of Sciences. 1003: 368-71. PMID 14684463 DOI: 10.1196/annals.1300.028  1
2003 Chartoff EH, Papadopoulou M, Konradi C, Carlezon WA. Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum. Journal of Neurochemistry. 87: 107-18. PMID 12969258 DOI: 10.1046/j.1471-4159.2003.01992.x  1
2001 Chartoff EH, Marck BT, Matsumoto AM, Dorsa DM, Palmiter RD. Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation. Proceedings of the National Academy of Sciences of the United States of America. 98: 10451-6. PMID 11517332 DOI: 10.1073/pnas.181356498  1
1999 Chartoff EH, Ward RP, Dorsa DM. Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy. The Journal of Pharmacology and Experimental Therapeutics. 291: 531-7. PMID 10525068  1
1997 Adams MR, Brandon EP, Chartoff EH, Idzerda RL, Dorsa DM, McKnight GS. Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 94: 12157-61. PMID 9342379 DOI: 10.1073/pnas.94.22.12157  1
1996 Newfeld SJ, Chartoff EH, Graff JM, Melton DA, Gelbart WM. Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGF-beta responsive cells. Development (Cambridge, England). 122: 2099-108. PMID 8681791  1
1995 Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH, Gelbart WM. Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics. 139: 1347-58. PMID 7768443  1
Show low-probability matches.